Tensions in the Strait of Hormuz are raising alarms about the stability of global pharmaceutical supply chains, with potential implications for the U.S. generic drug market, which relies heavily on manufacturing in India.
India supplies roughly 47% of all generic drugs dispensed in the U.S. by volume and depends on the Strait of Hormuz for key petroleum-based manufacturing inputs and outbound shipping, according to a March 16 report from CNBC. While there are no immediate shortages, experts warn that continued disruption could affect the availability and pricing of essential medicines, including antibiotics, diabetes and blood pressure drugs and statins.
U.S. distributors typically maintain 30 to 60 days of inventory and some Indian manufacturers reportedly have three to six months of supply. However, air freight rates out of India have surged 200% to 350% for some routes, and shipping delays tied to the closure are straining refrigerated cargo operations. The disruption is raising concerns about cold-chain failures for certain treatments, according to CNBC.
India’s limited energy reserves — just 10 days of liquified petroleum gas import cover — further underscore supply fragility. Industry leaders say generics are particularly vulnerable due to thin margins and tight logistics, especially as many active pharmaceutical ingredients pass through Gulf-region hubs before reaching Indian producers.
Still, pharmacy operators and trade groups say consumers should not panic. The Indian Pharmaceutical Alliance told CNBC manufacturers are “doing their very best to manage these disruptions,” and many are exploring reshoring options. Lupin, for example, recently announced a $250 million investment in a U.S. production facility in Florida.
This comes amid heightened concerns about cyber threats tied to the Iran conflict. On March 11, medical device maker Stryker reported a cyberattack on its Microsoft systems, which CNN attributed to pro-Iran hackers, though the company has not confirmed attribution. While U.S. hospital operations have not been disrupted, health systems such as Providence, Cleveland Clinic and Mass General Brigham said they are evaluating potential impacts and have taken precautionary steps.
The American Hospital Association said it remains in contact with federal agencies and has urged hospitals to report suspicious cyber or physical activity. The FBI issued an advisory March 3 reminding critical infrastructure organizations to strengthen cybersecurity in light of elevated geopolitical tensions.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
